Burnham & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Burnham & Co's ABBV Position: Q3 2026 in Review
Burnham & Co reduced its AbbVie (ABBV) stake by 0.58% in Q3 2026, selling an estimated $19.2K and leaving 12,828 shares worth $3.36M. The position accounts for 2.65% of the portfolio, ranked #13.
Burnham & Co first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Burnham & Co held 12,828 shares of AbbVie worth $3.36M as of Q3 2026.
- Burnham & Co sold 75 AbbVie shares in Q3 2026, an estimated $19.2K.
- AbbVie made up 2.65% of Burnham & Co's portfolio in Q3 2026, its #13 holding.
- Burnham & Co first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
- 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Burnham & Co's 13F filing for Q3 2026, filed 12 Nov 2026.